Physician profile
Sandra Perrett
NPI 1437753555
$1,855.76
in general payments reported to CMS, 2019-2025
17 companies · $771 in 2025
The $771 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.00 · 2024: $1,070 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,764 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.77 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $565.18 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $431.00 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $218.00 | 2024-2025 | Entyvio |
| Evoke Pharma, INC. | $143.50 | 2024 | |
| Janssen Biotech, INC. | $97.04 | 2025 | Tremfya |
| Madrigal Pharmaceuticals | $90.41 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.47 | 2021-2025 | Xifaxan, Plenvu |
| Ardelyx, INC. | $53.69 | 2024-2025 | Ibsrela |
| Pfizer INC. | $36.16 | 2025 | |
| Gilead Sciences, INC. | $24.96 | 2025 | |
| Intercept Pharmaceuticals, INC. | $22.69 | 2024 | |
| Ironwood Pharmaceuticals, INC | $21.92 | 2024 | |
| Lilly USA, LLC | $18.49 | 2024 | Omvoh |
| Fresenius Kabi USA, LLC | $17.58 | 2024 | Idacio |
| Ipsen Biopharmaceuticals, INC | $15.84 | 2024 | Iqirvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.49 | 2025 | Wegovy |
| Amgen INC. | $14.34 | 2025 | Uplizna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Perrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.